Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions

Koç Z. P., Özcan P. P., Güney İ. B.

molecular oncologic imaging, vol.2, no.3, pp.52-55, 2022 (Peer-Reviewed Journal)

  • Publication Type: Article / Case Report
  • Volume: 2 Issue: 3
  • Publication Date: 2022
  • Journal Name: molecular oncologic imaging
  • Page Numbers: pp.52-55
  • Çukurova University Affiliated: Yes

Abstract

Abstract F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation. This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.